June 9 (Reuters) - The weight-loss drug market is booming, with biotech firms racing to capture a slice of a fast-growing ...
IT should have been the trip of a lifetime… so when Sarah Smith couldn’t remember her best friend’s wedding in Fiji, it rang ...
Pfizer has received approval from the US Food and Drug Administration (FDA) for an expanded indication of Hympavzi ...
For India, where long-term adherence is a major challenge, a once-monthly GLP-1 therapy could improve patient acceptance and ...
Pfizer presents positive results from multiple phase 2b studies of GLP-1 RA, berobenatide at 86th Scientific Sessions of ADA: New York Tuesday, June 9, 2026, 13:00 Hrs [IST] Pfize ...